Treatment for diabetes in patients with insufficient glycemic control despite therapy… Grant US-11911388-B2 United States of America 27 Feb 2024
Vasoprotective and cardioprotective antidiabetic therapy Grant US-11911387-B2 United States of America 27 Feb 2024
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such… Grant US-10973827-B2 United States of America 13 Apr 2021
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as… Grant US-10202383-B2 United States of America 12 Feb 2019
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Grant US-10195203-B2 United States of America 05 Feb 2019
Medical use of pharmaceutical combination or composition Grant US-10155000-B2 United States of America 18 Dec 2018
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Grant US-10092571-B2 United States of America 09 Oct 2018
Treatment for diabetes in patients inappropriate for metformin therapy Grant US-10034877-B2 United States of America 31 Jul 2018
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such… Grant US-10022379-B2 United States of America 17 Jul 2018
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as… Grant US-10023574-B2 United States of America 17 Jul 2018
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant US-9751855-B2 United States of America 05 Sep 2017
Method for modifying food intake and regulating food preference with a DPP-4 inhibitor Grant US-9713618-B2 United States of America 25 Jul 2017
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as… Grant US-9556175-B2 United States of America 31 Jan 2017
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Grant US-9526730-B2 United States of America 27 Dec 2016
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant US-9499546-B2 United States of America 22 Nov 2016